AT
Ana Toplak
Biochemistry Lab Manager
Fresenius Kabi iPSUM
Is member of
Fresenius Kabi Contract Manufacturing
Featured Exhibitorsis attending
AI Disruption in Pharma: From Hype to Real Impact
Wednesday, October 29, 2025 10:00 AM to 10:30 AM
Hall 4.1 - 4.1L8
Off-Patent Semaglutide in 2026: The Next Revolution in Anti-Obesity Medications
Tuesday, October 28, 2025 12:15 PM to 12:40 PM
Hall 4.1 - 4.1J48
Aurelio Arias · IQVIA
Analytical Testing in ADC Development: From Cell Bank Characterization to Market Approval.
Wednesday, October 29, 2025 12:45 PM to 1:10 PM
Hall 4.1 - 4.1J48
Luc-Alain Savoy · SGS SA
Philippe Grimm · SGS VITROLOGY
Clinical Innovation in Obesity: The Next Five Years in Obesity Development
Wednesday, October 29, 2025 12:15 PM to 12:40 PM
Hall 6.1 - 6.1C92
Aurelio Arias · IQVIA